While 8771 ingredients have been accepted in China, twenty plant based ingredients were removed due to redundant names already on the list.
'Papaver somniferum seed extract' was the only material to be banned.
According to the Chemical Inspection & Regulation Service (CIRS), it's possible to supplement the new ingredients based on their previous use in approved cosmetics.
CIRS adds that the standard Chinese name of plant ingredients is referred from the INCI inventory (2010), Flora of China, Chinese Pharmacopoeia, Tibetan Medicine Standard and Mongolian Medicine Standard.
The English version of the revised inventory issued by CFDA can be accessed here.
'IECIC 2014'
In China, new cosmetic ingredients must be approved by Chinese food and drug administration authorities.
The China Food and Drug Administration (CFDA) previously relied on IECIC 2003, an internally circulated list of cosmetics ingredients, in determining whether an ingredient is new.
This proved challenging for the industry due to the limited number of ingredients on IECIC (2003) and the difficulty of getting a new ingredient approved.
To strengthen the safety management of cosmetic ingredients, the CFDA published a consolidated Inventory of Existing Cosmetic Ingredients in China (2014) for public consultation.
CIRS summit to address 'series of tremendous changes' in regulations
Asia has become of the biggest cosmetic markets in recent years, among which, China is the most prominent.
In an effort to help the industry get to grips with supervisory policies, CIRS hosted the region's 'first' regulations summit in June to provide a 'full understanding' of them.
According to April Guo, head of cosmetics regulatory affairs, Chinese regulations have experienced a "series of tremendous changes since 2014".
"Therefore, we invited officials from relevant Chinese government authorities to give a comprehensive analysis on cosmetic supervisory policies and their influence on enterprises, so that domestic and overseas corporations will have a deeper understanding," Guo tells CosmeticsDesign-Asia.com.
Experts from Japan, Korea and Malaysia were also invited by the CIRS appointed committee to interpret the current status of cosmetic management and help the industry on the latest regulatory updates and administrative information in these areas.